Mc Services Ag company information, Employees & Contact Information

PL BioScience Announces new Board Member Ole Henrik Bang-Andreasen TradingView

InflaRx Announces Participation in the Guggenheim Securities 2nd Annual Healthcare Innovation Conference Sahm

Mainz Biomed to Attend 2025 Maxim Growth Summit GlobeNewswire

AFYREN Announces Its 2025 Half-Year Financial Results Business Wire

Rentschler Biopharma further expands its services in Japan GlobeNewswire

Newron to Present New Analyses From and Updates on its Clinical Program Evaluating Evenamide as an Add-on Treatment for Schizophrenia at the 38th European College of Neuropsychopharmacology (ECNP) Congress 2025 Business Wire

Nyxoah Announces Upcoming Investor Events | News | starkvilledailynews.com FinancialContent

AFYREN Receives €4 Million in Grants for AFYREN NEOXY and Starts New Performance-Driven Investment Strategy Business Wire

Mainz Biomed Announces Commercial Launch of ColoAlert® in Switzerland GlobeNewswire

Mainz Biomed Announces Registration of ColoAlert in the United Kingdom GlobeNewswire

Newron presents H1 2025 results and provides business update Business Wire

MRM Health Raises €55 Million Series B to Advance Best-in-Class Microbiome-Based Biotherapeutic Product Pipeline Business Wire

Saudi Arabia to Showcase Ambitious Biotech Agenda at BIO 2025 GlobeNewswire

AFYREN Begins New Phase of Industrial Strategy as First Plant AFYREN NEOXY Achieves Continuous Production Business Wire

Mainz Biomed N.V. Regains Compliance with Nasdaq Capital Market Listing Requirements GlobeNewswire

Newron to present data and updates on its clinical program evaluating evenamide as an add-on treatment for schizophrenia at the 2025 World Congress of Biological Psychiatry (WCBP) Business Wire

AFYREN Announces Its 2024 Full-Year Financial Results Business Wire

Newron Announces Approval for Pivotal Phase III ENIGMA-TRS Program With Evenamide as Add-on Therapy in Patients With Treatment-resistant Schizophrenia (TRS) Business Wire

Newron Pharmaceuticals to Participate in a Fireside Chat at the 37th Annual ROTH Conference Business Wire

AFYREN Provides Business Update and Announces a €10 Million Sustainable Financing for Its Subsidiary AFYREN NEOXY Business Wire

Nyxoah Announces Commercial Launch of Genio® Breakthrough Therapy in the Middle East Macau Business

Mainz Biomed and Thermo Fisher Scientific Sign a GlobeNewswire

Mainz Biomed Partners with CARE Diagnostica to Enhance Colorectal Cancer Screening in Germany Quiver Quantitative

Mainz Biomed Receives Swiss Regulatory Approval to Market ColoAlert® GlobeNewswire

Meliodays and Celanese Partner for Meliodays’ Development GlobeNewswire

Mainz Biomed N.V. Completes Follow-On Offering Raising Approximately $8 Million Quiver Quantitative

Mainz Biomed Secures Public Funding to Advance Innovative Pancreatic Cancer Screening Test GlobeNewswire

Mainz Biomed Enters into Technology Partnership with EDX Medical Group GlobeNewswire

Mainz Biomed Expands into Switzerland with labor team w GlobeNewswire

BioLizard Welcomes Arjan van Manen as Commercial Director GlobeNewswire

Andera Partners to sell its Life Sciences’ portfolio company ReViral to Pfizer Business Wire

Nyxoah Rings the Closing Bell at Nasdaq while Preparing for U.S. Market Launch of Innovative Sleep Apnea Device Nasdaq

TVM Capital Life Science Leads €23 Million Series C GlobeNewswire

Newron Pharmaceuticals 2024 Investor Day on June 25, 2024, in New York City Business Wire

FDA Clears Path Forward for Nyxoah's Revolutionary Sleep Apnea Treatment Stock Titan

TVM Capital Life Science Announces €8 Million Investment in GlobeNewswire

Syntekabio Appoints Joonhyuk Choi, Former Target Health CEO, as Head of US Operations ACCESS Newswire

Abivax Releases the Results of its June 5, 2023 Ordinary and Extraordinary General Meeting Yahoo Finance

Carbios Places Sustainability at the Heart of its Governance with New Appointment to its Executive Committee Business Wire

Apogenix to Present at AACR Virtual Annual Meeting II ACCESS Newswire

Carbios and Indorama Ventures Reaffirm Partnership to Build First-of-a-kind PET Biorecycling Plant in France Business Wire

Nyxoah Reports Second Quarter Financial and Operating Results Finansavisen

MRM Health Raises €55 Million Series B to Advance Best-in-Class Microbiome-Based Biotherapeutic Product Pipeline Via TT

Leading fashion company joins fiber-to-fiber consortium founded by Carbios, On, Patagonia, PUMA and Salomon Business Wire

Nyxoah Announces Preliminary Results for the Second Quarter of 2025 Finansavisen

Carbios Obtains Building and Operating Permits, in Line With Announced Schedule, for World's First PET Biorecycling Plant in Longlaville The AI Journal

EQS-News: AATec Medical and Northway Biotech Announce Partnership to Develop Industrial Production Process for ATL-105 Targeting Lung Diseases - boerse.de boerse.de

CARBIOS and FCC Environment announce joint project to establish UK-based PET biorecycling facility using CARBIOS’ licensed technology FCC Environment

CARBIOS and TOMRA Textiles join forces to scale circularity of polyester textiles NTB Kommunikasjon

Pharnext Announces FDA Fast Track Designation for PLEODRUG(TM) PXT3003 for the Treatment of Charcot-Marie-Tooth Disease Type 1A ACCESS Newswire

DGAP-News: MIG Fonds invests in German Bionic Systems - boerse.de boerse.de